Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): A randomised controlled trial

The Lancet Oncology

Volumn 13, Issue 3, 2012, Pages 309-318

  Mann, Eleanor ^a   Smith, Melanie J ^a   Hellier, Jennifer ^a   Balabanovic, Janet A ^a   Hamed, Hisham ^b   Grunfeld, Elizabeth A ^c   Hunter, Myra S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CLONIDINE; FLUOXETINE; HERBACEOUS AGENT;

ADULT; AGE; ARTICLE; BREAST CANCER; BREATHING EXERCISE; CANCER RADIOTHERAPY; CANCER SURVIVOR; CANCER THERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NIGHT SWEAT; OUTCOME ASSESSMENT; PACED BREATHING; PRIORITY JOURNAL; PSYCHOEDUCATION; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM;

AFFECT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITIVE THERAPY; FEMALE; HOT FLASHES; HUMANS; LINEAR MODELS; LONDON; MASTECTOMY; MENOPAUSE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; SLEEP; SWEATING; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857506598     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70364-3     Document Type: Article

References (34)

1. Cancer Statistics registrations: registrations of cancer diagnosed in 2008, England 2010, Office for National Statistics, National Statistics, London.
2. Carpenter J, Johnson D, Wagner L, Andrykowski M Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002, 29:16-25.
3. Hunter MS, Grunfeld EA, Mittal S, et al. Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncology 2004, 13:769-778.
4. Gupta P, Sturdee D, Palin S, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 2006, 9:49-58.
5. Howell A, Cuzick J, Baum M, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005, 365:60-62.
6. Cella D, Fallowfield LJ Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 2008, 107:167-180.
7. Lash T, Fox M, Westrup J, Fink A, Silliman R Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 2006, 99:215-220.
8. Pradhan A, Manson J, Rossouw J, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002, 288:980-987.
9. Rada G, Capurro D, Pantoja T, et al. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev 2010, 9. CD004923.
10. Butt DA, Lock M, Lewis J, Ross S, Moineddin R Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Menopause 2008, 15:310-318.
11. Buijs C, Mom CH, Willemse PH, et al. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study. Breast Cancer Res Treat 2009, 115:573-580.
12. Biglia N, Sgandurra P, Peano E, et al. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs vitamin E. Climacteric 2009, 12:310-318.
13. Loibl S, Lintermans A, Dieudonné AS, Neven P Management of menopausal symptoms in breast cancer patients. Maturitas 2011, 68:148-154.
14. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000, 356:2059-2063.
15. Maki P New data on mindfulness-based stress reduction for hot flashes: how do alternative therapies compare with selective serotonin reuptake inhibitors?. Menopause 2011, 18:596-598.
16. Kaplan M, Mahon S, Cope D, Keating E, Hill S, Jacobson M Putting evidence Into practice: Evidence-based interventions for hot flashes resulting from cancer therapies. Clin J Oncol Nurs 2011, 15:149-157.
17. Hunter MS, Liao KLM Evaluation of a four-session cognitive-behavioural intervention for menopausal hot flushes. Br J Health Psychol 1996, 1:113-125.
18. Hunter MS, Coventry S, Hamed H, Fentiman I, Grunfeld EA Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment. Psychooncology 2009, 18:560-563.
19. Hunter MS, Mann E A cognitive model of menopausal hot flushes and night sweats. J Psychosom Res 2010, 69:491-501.
20. Mann E, Smith MS, Hellier J, Hunter MS A randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): trial protocol. BMC Cancer 2011, 11:44.
21. Rand KL, Otte JL, Flockhart D, et al. Modeling hot flushes and quality of life in breast cancer survivors. Climacteric 2011, 13:171-180.
22. Carpenter J, Rand K Modeling the hot flash experience in breast cancer survivors. Menopause 2008, 15:469-475.
23. Mann E, Hunter MS Concordance between self-reported and sternal skin conductance measures of hot flushes in symptomatic menopausal women: a systematic review. Menopause 2011, 18:709-722.
24. Hunter MS, Liao KLM A psychological analysis of menopausal hot flushes. Br J Clin Psychol 1995, 34:589-599.
25. Hunter MS The women's health questionnaire (WHQ): frequently asked questions (FAQ). Health Qual Life Outcomes 2003, 1:41.
26. Ware JE, Kosinski M, Gandek B SF-36 health survey: manual and interpretation guide 2000, QualityMetric Incorporated, Lincoln, RI.
27. Hunter MS The women's health questionnaire (WHQ): the development, standardization and application of a measure of mid-aged women's emotional and physical health. Qual Life Res 2000, 9:733-738.
28. Joint project guidance notes on pharmacovigilance Medical Research Council and Department for Health, (accessed Sept 5, 2011). http://www.ct-toolkit.ac.uk/_db/_documents/Joint_Project_Guidance_on_Pharmacovigilance.pdf.
29. Wampold BE, Brown GS Estimating variability in outcomes attributable to therapists: a naturalistic study of outcomes in managed care. J Consult Clin Psychol 2005, 73:914-923.
30. Savard MH, Savard J, Trudel-Fitzgerald C, Ivers H, Quesnel C Changes in self-reported hot flashes and their association with concurrent changes in insomnia symptoms among women with breast cancer. Menopause 2011, 18:985-993.
31. Ayers B, Smith M, Hellier J, Mann E, Hunter MS. Effectiveness of group and self-help cognitive behaviour therapy to reduce problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause (in press).
32. Germaine L, Freedman R Behavioural treatment of menopausal hot flashes: evaluation by ambulatory monitoring. J Consult Clin Psychol 1984, 52:1072-1079.
33. Duijts S, Oldenburg H, Van Beurden M, Aaronson N Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment induced menopause: first results of a multicenter trial. Psychooncology 2010, 19(suppl 2):58-59.
34. Carpenter J, Neal J, Payne J, Kimmick G, Storniolo A Cognitive behavioral intervention for hot flashes. Oncol Nurs Forum 2007, 34:E1-E8.